INS and polycystic ovary syndrome: The resultant metabolic network remodeling—characterized by enhanced insulin sensitivity, optimized hepatic glucose/lipid output, reduced adipose tissue inflammation, suppressed ovarian androgenesis, restored central energy balance, and normalized reproductive endocrine rhythms—collectively reverses the core pathological features of PCOS.